NCT06191133 2025-10-02
Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
Case Comprehensive Cancer Center
Phase 1 Recruiting
Clinical Trials
28 trialsNCT04131413 2025-08-24
HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Recruiting
NCT06165614 2025-08-19
Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT06263582 2025-08-19
Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT06137950 2025-04-03
Interferon Alpha Therapy for Cervical CINI and HPV Infection
Mongolian National University of Medical Sciences
Phase 1 Completed
NCT00667563 2024-03-19
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
AIDS Malignancy Consortium
Phase 1 Completed
NCT00788164 2023-08-31
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT03226470 2022-01-14
Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions
Huazhong University of Science and Technology
Phase 1 Unknown
NCT03321461 2021-06-30
TMTP1-ICG Mapping in Colposcopy-directed Biopsy
Huazhong University of Science and Technology
Phase 1 Unknown
NCT02354534 2021-04-28
Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT03697226 2021-01-13
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
Antiva Biosciences
Phase 1 Completed
NCT04411134 2020-07-15
E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia
National Institutes of Health Clinical Center (CC)
Phase 1 Withdrawn
NCT03239223 2019-07-10
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
Antiva Biosciences
Phase 1 Completed
NCT03870113 2019-03-14
DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2
Shenzhen People's Hospital
Phase 1 Unknown
NCT00988559 2018-07-09
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00004261 2018-02-22
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
University Health Network, Toronto
Phase 1 Terminated
NCT00278434 2017-11-24
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
University of California, San Francisco
Phase 1 Terminated
NCT02800369 2017-07-12
Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous Lesions
Huazhong University of Science and Technology
Phase 1 Unknown
NCT03057912 2017-06-09
A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial Neoplasiaâ…
First Affiliated Hospital, Sun Yat-Sen University
Phase 1 Unknown
NCT00629577 2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1 Terminated
NCT00503919 2016-04-08
Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT01338051 2014-04-21
PERCAPS
Preventive Oncology International, Inc.
Phase 1 Completed
NCT01634503 2014-02-17
CIN3
Genexine, Inc.
Phase 1 Completed
NCT01035580 2013-11-28
Trial on Safety and Pharmacokinetics of Intravaginal Curcumin
Emory University
Phase 1 Completed
NCT01880411 2013-06-19
Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine
HealthBanks Biotech Co., Ltd.
Phase 1 Unknown
NCT00005808 2013-02-07
Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00989443 2010-10-21
Safety and Tolerability of Cidofovir Gel Applied on Cervix Squamous Lesions
Mithra Pharmaceuticals
Phase 1 Completed
NCT00493545 2008-05-07
Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia
Nventa Biopharmaceuticals Corporation
Phase 1 Unknown